Selected article for: "absolute increase and low infection"
Author: Kuznik, B. I.; Smolyakov, Yu. N.; Shapovalov, Yu. K.; Shapovalov, K. G.; Lukyanov, S. A.; Parts, D. S.
Title: The State of Microcirculatory Hemodynamics in Patients with Moderate and Severe COVID-19
  • Cord-id: sii3aqkc
  • Document date: 2021_9_20
    • ID: sii3aqkc
    Snippet: Microcirculatory hemodynamic indexes (HI) were assessed in patients with moderate and severe COVID-19. In both groups, a significant increase in the absolute spectral indexes (HI1, HI2, and HI3) and the ratio of low-frequency to high-frequency component (HI1/HI3) was revealed. In the group of severe infection, only the “slow” index (low-frequency HI1) of microcirculatory hemodynamics was significantly lower. The oscillatory indices MAYER1-3 and RESP1-3 were reduced in patients of both groups
    Document: Microcirculatory hemodynamic indexes (HI) were assessed in patients with moderate and severe COVID-19. In both groups, a significant increase in the absolute spectral indexes (HI1, HI2, and HI3) and the ratio of low-frequency to high-frequency component (HI1/HI3) was revealed. In the group of severe infection, only the “slow” index (low-frequency HI1) of microcirculatory hemodynamics was significantly lower. The oscillatory indices MAYER1-3 and RESP1-3 were reduced in patients of both groups. The aggravation of the disease course was accompanied by depression of the low-frequency index HI1. Regulatory shifts compensate for disturbances in microcirculatory processes in moderate COVID-19, but severe course was associated with their decompensation.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and lmwh low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lopinavir ritonavir hydroxychloroquine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute ards respiratory distress syndrome and low frequency: 1
    • acute ards respiratory distress syndrome and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute ards respiratory distress syndrome and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute sars coronavirus cause respiratory syndrome and lopinavir ritonavir: 1, 2, 3
    • acute sars coronavirus cause respiratory syndrome and lopinavir ritonavir hydroxychloroquine: 1, 2
    • acute sars coronavirus cause respiratory syndrome and lopinavir ritonavir hydroxychloroquine include: 1
    • acute sars coronavirus cause respiratory syndrome and low molecular weight: 1
    • acute sars coronavirus cause respiratory syndrome and low molecular weight heparin: 1
    • additional measure and administration rate: 1
    • adhesion molecule and low frequency: 1
    • administration rate and lopinavir ritonavir: 1, 2, 3
    • administration rate and low frequency: 1
    • lmwh low molecular weight heparin and lopinavir ritonavir: 1, 2, 3
    • lmwh low molecular weight heparin and lopinavir ritonavir hydroxychloroquine: 1, 2, 3
    • lmwh low molecular weight heparin and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • lmwh low molecular weight heparin and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25